A Trial of Pulmozyme Withdrawal on Exercise Tolerance in Cystic Fibrosis Subjects With Severe Lung Disease (TOPIC)

Clinical trial NCT00434278 · TERMINATED

Trial details

NCT number: NCT00434278
Sponsor: Genentech, Inc.
Status: TERMINATED
Phase: Phase 4
Study type: INTERVENTIONAL

Cystic Fibrosis

Start date: 2007-03-01
Primary completion: 2008-11-01
Enrollment: 27

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.